Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
100.0%
% of XLV's 60 holdings also in FHLC
18.6%
% of FHLC's 349 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus FHLC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in FHLC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 11.3% | 11.3% |
|
UNITEDHEALTH GROUP INC | 8.5% | 7.3% | 7.3% |
|
JOHNSON & JOHNSON | 7.7% | 6.4% | 6.4% |
|
ABBVIE INC | 6.2% | 6.1% | 6.1% |
|
MERCK & CO. INC. | 4.0% | 3.8% | 3.8% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to FHLC
|
ELI LILLY & CO | 2.1% |
|
JOHNSON & JOHNSON | 1.2% |
|
UNITEDHEALTH GROUP INC | 1.2% |
|
ABBOTT LABORATORIES | 0.8% |
|
INTUITIVE SURGICAL INC | 0.5% |
|
VERTEX PHARMACEUTICALS INC | 0.5% |
|
BOSTON SCIENTIFIC CORP | 0.5% |
|
ELEVANCE HEALTH INC | 0.5% |
|
MCKESSON CORP | 0.5% |
|
CIGNA CORPORATION | 0.4% |
XLV Underweight Relative to FHLC
|
VEEVA SYSTEMS INC-CLASS A | -0.6% |
|
ALNYLAM PHARMACEUTICALS INC | -0.5% |
|
NATERA INC | -0.3% |
|
ILLUMINA INC | -0.2% |
|
BIOMARIN PHARMACEUTICAL INC | -0.2% |
|
UNITED THERAPEUTICS CORP | -0.2% |
|
ROYALTY PHARMA PLC CLASS A | -0.2% |
|
INTRA-CELLULAR THERAPIES INC | -0.2% |
|
INSMED INC | -0.2% |
|
TENET HEALTHCARE CORP | -0.2% |